多学科协作抗菌治疗前标本送检闭环管理及其效果评价

Closed-loop management of specimen examination before antibacterial therapy under multidisciplinary collaboration and its effect

  • 摘要:
    目的 分析并评价抗菌药物治疗前病原学送检率全流程闭环管理, 对多重耐药菌防控、缩短住院时长等医疗质量指标的影响。
    方法 选取2023年4月1日-2024年9月30日北京某三甲医院感染内科、呼吸内科及重症医学科住院患者为研究对象, 观察项目实施前后抗菌药物及联合使用重点抗菌药物治疗前病原学送检率、医院感染诊断相关病原学送检率、抗菌药物使用强度、标本转运/送检时间、住院天数以及耐碳青霉烯类铜绿假单胞菌(CRPA)、耐碳青霉烯类肺炎克雷伯菌(CRKP)、耐碳青霉烯类鲍曼不动杆菌(CRAB)、耐碳青霉烯类大肠埃希菌(CREC)及耐甲氧西林金黄色葡萄球菌(MRSA)的检出率。
    结果 实施后重点科室住院患者抗菌药物治疗前病原学送检率(94.72%)高于实施前(93.59%)(χ2=5.128, P=0.024);实施后使用限制/非限制类、特殊及碳青霉烯类药物治疗前特定病原学送检率等指标均超过95%;CRKP检出率由50.97%降至42.71%, CREC、CRPA检出率降低(8.18% vs. 7.69%、53.30% vs. 46.84%), CRAB由85.50%降至83.21%, MRSA由48.94%降至48.65%,但差异无统计学意义;研究期间抗菌药物使用强度无明显变化, 实施前后重症医学科患者标本转运/送检时间缩短(P<0.05);感染内科及呼吸内科患者住院天数缩短(P<0.05)。
    结论 项目实施后病原学送检率指标均提高, 目标耐药菌检出率变化不明显, 显著缩短标本送检时间及患者住院时间。

     

    Abstract:
    OBJECTIVE To analyze and evaluate the impact of whole-process closed-loop management of pathogen examination rate before antibacterial agent therapy on medical quality indicators such as the prevention and control of multidrug-resistant bacteria and the shortening of hospital stay.
    METHODS Patients admitted to the infectious disease department, respiratory medicine department and critical care medicine department of a three-A hospital in Beijing from Apr. 1, 2023 to Sep. 30, 2024 were selected as the study subjects. Before and after the implementation of the project, the pathogen examination rate before antibacterial agent therapy and combined use of major antibacterial agents for therapy, the pathogen examination rate related to hospital-associated infection diagnosis, the intensity of antibacterial agent use, specimen transportation/examination time, length of hospital stay and the detection rates of carbapenem-resistant Pseudomonas aeruginosa (CRPA), carbapenem-resistant Klebsiella pneumoniae (CRKP), carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Escherichia coli (CREC) and methicillin-resistant Staphylococcus aureus (MRSA) were observed.
    RESULTS After implementation, the pathogen examination rate of hospitalized patients in key departments before antibacterial agent therapy (94.72%) was higher than that before implementation (93.59%) (χ2=5.128, P=0.024); the specific pathogen examination rate and other indicators before the use of restricted/non-restricted, special and carbapenem agents exceeded 95%. The detection rate of CRKP decreased from 50.97% to 42.71%, the detection rates of CREC and CRPA decreased (8.18% vs. 7.69%, 53.30% vs. 46.84%), CRAB decreased from 85.50% to 83.21%, MRSA decreased from 48.94% to 48.65%, and there were no significant differences. There was no significant change in the intensity of antibacterial agent use during the study period, and the specimen transportation/examination time for patients from the critical care medicine department was shortened after implementation (P < 0.05). The length of hospital stay for patients from the infectious disease department and respiratory medicine department was shortened (P < 0.05).
    CONCLUSION After the implementation of the project, the pathogen examination rate indicators increase, the target drug-resistant bacterium detection rate does not change sianificantly, and the specimen examination time and patient hospital stay are significantly shortened.

     

/

返回文章
返回